PRS26 Economic Evaluation of Omalizumab in Patients With Uncontrolled Severe Allergic Asthma From the Public Payer Perspective in Brazil
Suzuki, C ; Pepe, C ; Silva, N.L
Value in health, 2012-11, Vol.15 (7), p.A564-A564
[Periódico revisado por pares]
Elsevier Inc
Texto completo disponível